Trade LIMN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Liminatus Pharma, Inc. Class A (LIMN) is trading at US$4.08, up 11.95% today as of Sep 22, 13:43 EDT. The company has a market capitalisation of US$6.93M. Over the past 52 weeks, LIMN has traded between US$3.29 and US$141.50. On Syfe you can trade LIMN with $0 commission and add it to your watchlist.
| Previous close | US$3.64 |
|---|---|
| Market cap | US$6.93M |
| 52-week range | US$3.29 – US$141.50 |
| Volume | 15.96K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Liminatus Pharma, Inc. Class A
Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
Year: 2025
Liminatus Pharma Reports Reverse Stock Split
Aug 18, 8:51 PM · MT Newswires
Top Premarket Gainers
Jul 2, 11:09 AM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
Jul 1, 1:20 PM · MT Newswires
Liminatus Pharma Amends Merger Deal With InnocsAI
Jul 1, 11:25 AM · MT Newswires
Top Premarket Decliners
May 22, 11:42 AM · MT Newswires
Liminatus Pharma, Inc. Class A (LIMN) stock is trading at US$4.08, +11.95% from the previous close of US$3.64.
The market cap for Liminatus Pharma, Inc. Class A (LIMN) stock is approximately US$6.93M.
The 52-week high for Liminatus Pharma, Inc. Class A (LIMN) stock is US$141.50.
The 52-week low for Liminatus Pharma, Inc. Class A (LIMN) stock is US$3.29.
Liminatus Pharma, Inc. Class A (LIMN) does not currently pay a dividend.
Stay on top of LIMN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
